Oncology Products - Bioreagent - Bertin Pharma

dickeyarmBiotechnology

Dec 10, 2012 (4 years and 6 months ago)

334 views

A wide range of analytical standards now available
for your research
Parc d’activités du Pas du Lac - 10 bis avenue Ampère
F-78180 Montigny le Bretonneux
Tel: 33 139 306 036 – Fax: 33 139 306 299
Email: bioreagent@bertinpharma.com - www.bertinpharma.com
Oncology
Products
 5-Doxifluridine-D
2
(5-DFUR-D
2
) MI7902
 5,6-dihydrofluorouracil MR8035
 Anastrozole AP8079
 Capecitabine AP8085
 Capecitabine-D
8
MI7986
 Carboplatin AP8086
 Catharantine AP8089
 Deoxy-5-fluorocytidine (5-DFCR) MM7899
 Deoxy-5-fluorocytidine-D
2
(5-DFCR-D
2
) MI7900
 Docetaxel AP8100
 Doxifluridine (5-DFUR) MM7901
 Drostanolone propionate AP8103
 Leurosine AP8126
 Methotrexate AP8131
 Paclitaxel AP8183
 Tabersonine AP8158
 Tamoxifen citrate AP8160
 Temozolomide AP8161
 Vinblastine sulfate AP8172
 Vincristine sulfate AP8173
 Vindoline AP8174
Bertin Pharma has now available a large range of oncology analytical standards.
Oncology cancer treatment is a global healthcare priority. Over 20 million new cases
of cancer were predicted in 2025, compared with 12 million in 2008 (WHO).
Furthermore, anti-cancer drug sales exceeded $50bn worldwide in 2009. Increasing
disease prevalence and a strong R&D pipeline make the anti-cancer sector dynamic
and highly promising for pharmaceutical and biotechnology companies worldwide.
You will find below our list of analytical standards & related products for most of the
targets:
RELATED PRODUCTS
Cell Cycle Phase Determination Kit 10009349
DNA Methylation EIA Kit 589324
Cayman Cancer mini topical catalogue
Our range of oncology products
Oncology Flyer
2/2
Oncology V04 – Jan. 2012
Your Partner in Innovative Drug Development